Skip to main content
logo
Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
2.510
-0.050 (-1.95%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Tvardi Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---20.9741.8723.03
Revenue Growth
----49.92%81.81%-82.95%
Gross Profit
---14.7934.623.03
Operating Income
-29.45-26.75-28.11-121.5-87.54-89.08
Net Income
4.17-18.21-29.4-118.51-85.47-88.44
Earnings Per Share
-3.10-3.26-11.42-0.91-57.36-62.64
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
24.9830.8131.61100.76145.4167.04
Total Debt
0.170.20.36.091.923.67
Net Cash (Debt)
24.8130.6131.3194.67143.48163.36
Net Cash Growth
-27.50%-2.24%-66.93%-34.02%-12.17%-7.00%
Net Cash Per Share
2.713.9312.1663.5296.27115.95

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-24.67-23.5-18.31-92.08-78.73-60.09
Capital Expenditures
----2.38-0.04-0.04
Free Cash Flow
-24.67-23.5-18.31-94.45-78.77-60.13
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---70.56%82.64%100.00%
Operating Margin
----579.43%-209.08%-386.85%
Pretax Margin
----565.21%-204.16%-384.06%
Profit Margin
----565.21%-204.16%-384.06%
FCF Margin
----450.46%-188.15%-261.10%